AQR Capital Management
RCPI

AQR Capital Management’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

AQR Capital Management’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,216
Closed -$9K – 2745
2014
Q3 		$9K Sell
1,216
-2,568
-68% -$25.4K ﹤0.01% 2504
2014
Q2 		$56K Buy
+3,784
New +$65.7K ﹤0.01% 2492

Other funds holding RCPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AQR Capital Management's RCPI Position: Q4 2014 in Review

AQR Capital Management sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2014, closing a stake of 1,216 shares — an estimated $9K sold.

AQR Capital Management first reported a position in RCPI in Q2 2014 and held it in 2 quarters. The position peaked at $56K in Q2 2014. 55 funds tracked by Wall St. Rank hold RCPI as of Q4 2014.

  • AQR Capital Management reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • AQR Capital Management sold 1,216 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2014, an estimated $9K.
  • AQR Capital Management first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 2 quarters.
  • AQR Capital Management's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $56K in Q2 2014.
  • 55 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2014.

Based on AQR Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.